Wow, you guys got guts and more power to you, but I would never even consider to short a company's stock that is valued below 100 million market cap especially since the bankruptcy issue is no longer a possible....imo. Why even chance it? Sure, the earnings here are light but you are talking about rock bottom in price, and the drug is FDA market approved, with decent growth possible. And big pharma likes to buy companies on the cheap with approved drugs that they can possibly market much better.
That said, short the price down if you can....I am set to make money either way. :)